Down-regulation of miR-106b suppresses the growth of human glioma cells
详细信息    查看全文
  • 作者:Anling Zhang (1)
    Jianwei Hao (1)
    Kun Wang (1)
    Qiang Huang (1)
    Kai Yu (1)
    Chunsheng Kang (1)
    Guangxiu Wang (1)
    Zhifan Jia (1)
    Lei Han (1)
    Peiyu Pu (1)
  • 关键词:Glioma ; miR ; 106b Expression ; miR ; 106b ASON ; RBL2
  • 刊名:Journal of Neuro-Oncology
  • 出版年:2013
  • 出版时间:April 2013
  • 年:2013
  • 卷:112
  • 期:2
  • 页码:179-189
  • 全文大小:1308KB
  • 参考文献:1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-08 CrossRef
    2. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, Version 2.0. IARC CancerBase No. 5. IARC, Lyon
    3. Tran B, Rosenthal MA (2010) Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci 17(4):417-21 CrossRef
    4. Lawler S, Chiocca EA (2009) Emerging functions of microRNAs in glioblastoma. J Neurooncol 92(3):297-06 CrossRef
    5. Griffiths-Jones S, Saini HK, van Dongen S et al (2008) MiRBase: tools for microRNA genomics. Nucleic Acids Res 36:154-58 CrossRef
    6. Calin GA, Sevignani C, Dumitru CD et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101(9):2999-004 CrossRef
    7. Hummel R, Maurer J, Haier J (2011) Clinical role of MiRNAs in different brain tumors. Tumors Central Nerv Syst 3(2):185-92 CrossRef
    8. Petrocca F, Visone R, Onelli MR et al (2008) E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13:272-86 CrossRef
    9. Ventura A, Young AG, Winslow MM et al (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132:875-86 CrossRef
    10. Koralov SB, Muljo SA, Galler GR et al (2008) Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132:860-74 CrossRef
    11. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-08 CrossRef
    12. Zhang C, Kang C, You Y et al (2009) Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol 34:1653-660 CrossRef
    13. Hui AB, Lenarduzzi M, Krushel T et al (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16(4):1129-139 CrossRef
    14. Chen Y, Liu W, Chao T et al (2008) MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett 272:197-05 CrossRef
    15. Zhang Y, Chao T, Li R et al (2009) MicroRNA- 128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med 87:43-1 CrossRef
    16. Ciafrè SA, Galardi S, Mangiola A et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351-358 CrossRef
    17. Zhou X, Ren Y, Moore L et al (2010) Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 90:144-55 CrossRef
    18. Zhang C, Kang CS, You Y et al (2009) Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol 34(6):1653-660
    19. Nan Y, Han L, Zhang A et al (2010) MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 4(1359):14-1 CrossRef
    20. Wang YX, Zhang XY, Zhang BF et al (2010) Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 11(1):50-4 CrossRef
    21. Liu W, Gong YH, Chao TF et al (2009) Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas. Chin Med J (Engl) 122(20):2405-411
    22. Kan T, Meltzer SJ (2009) MicroRNAs in Barrett’s esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 9(6):727-32 CrossRef
    23. Rao SA, Santosh V, Somasundaram K (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 10:1404-417 CrossRef
    24. Schraivogel D, Weinmann L, Beier D et al (2011) CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J 30(20):4309-322 CrossRef
    25. Ivanovska I, Ball AS, Diaz RL et al (2008) MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 4:2167-174 CrossRef
    26. Park KM, Kim DJ, Paik SG et al (2006) Role of E2F1 in endoplasmic reticulum stress signaling. Mol Cells 21(3):356-59
    27. Trompeter HI, Abbad H, Iwaniuk KM et al (2011) MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS ONE 6(1):16138-6150 CrossRef
    28. Sdek P, Zhao P, Wang Y et al (2011) Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes. J Cell Biol 194(3):407-23 CrossRef
    29. Kheirollahi M, Mehr-Azin M, Kamalian N et al (2011) Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors. Med Oncol 28(1):7-4 CrossRef
    30. Haller F, L?bke C, Ruschhaupt M et al (2008) Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). J Pathol 215(3):253-62 CrossRef
    31. Cobrinik D (2005) Pocket proteins and cell cycle control. Oncogene 24:2796-809 CrossRef
    32. Araki K, Nakajima Y, Eto K et al (2003) Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Oncogene 22:7632-641 CrossRef
  • 作者单位:Anling Zhang (1)
    Jianwei Hao (1)
    Kun Wang (1)
    Qiang Huang (1)
    Kai Yu (1)
    Chunsheng Kang (1)
    Guangxiu Wang (1)
    Zhifan Jia (1)
    Lei Han (1)
    Peiyu Pu (1)

    1. Department of Neurosurgery; Tianjin Medical University General Hospital; Tianjin Neurological Institute; Key Laboratory of Post-trauma Neuro-repair and Regeneration of the Central Nervous System, Ministry of Education; Tianjin Key Laboratory of Injuries, Variations and Regeneration of the Nervous System, 154 Anshan Road, Heping District, Tianjin, 300052, People’s Republic of China
  • ISSN:1573-7373
文摘
Recently, many studies have found that the miR-106b?~25 cluster plays an oncogenic role in tumor progression. However, the precise role of each microRNAs (miRNAs) in the cluster is not yet clear. In the present study, we examined the expression of miR-106b in glioma samples and a tissue microarray by real-time PCR and in situ hybridization (ISH), respectively, finding that miR-106b is overexpressed in the majority of gliomas. Meanwhile, the expression of miR-106b was positively correlated with tumor grade (p?<?0.05). The transfection of a miR-106b anti-sense oligonucleotide (ASON) into three human glioma cell lines (U251, LN229 and TJ905) suppressed the proliferation of these cells. Moreover, the growth of xenograft tumors in nude mice treated with miR-106b ASON was significantly impaired. A bioinformatics analysis predicted that RBL2 may be the target of miR-106b, and dual-luciferase reporter assays identified RBL2, but not RB1 or RBL1, as a target of miR-106b. These results suggest that miR-106b facilitates glioma cell growth by promoting cell cycle progression through the negative regulation of RBL2.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700